REQUEST A DEMO
Total
USD $0.00
Search more companies

Medinco Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Cosmetics, Beauty Supplies, and Perfume Stores | All Other Professional, Scientific, and Technical Services | Convention and Trade Show Organizers | All Other Miscellaneous Schools and Instruction | Educational Support Services | Electronic and Precision Equipment Repair and Maintenance | Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance
Full name: Medinco Sp. z o.o. Profile Updated: September 25, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Medinco Sp. z o.o. operates as a med-tech distribution and service organization focused on introducing and implementing advanced medical technologies in Poland and the CEE region, with a long operating history and family ownership. The business model combines equipment distribution, technical maintenance and after-sales support, complemented by specialist training and education for medical personnel, aligning the company with healthcare providers seeking clinically validated solutions and reliable lifecycle service. The companys core human-health line is positioned around ultrasound technologies, including exclusive partnership responsibilities for distribution and maintenance of GE Healthcare ultrasound systems in the human medical market in Western Poland, integrating equipment supply with servicing, uptime support and user enablement. In parallel, the group structure includes a veterinary-focused line that acts as an exclusive partner in Poland for Mindray Animal Medical solutions across medical imaging and patient life monitoring systems, addressing clinics and veterinary hospitals with both devices and operational support. A dedicated education platform expands the asset base into professional training and competency development for healthcare professionals using modern med-tech, supporting technology adoption and standardization. The organization also references innovation partnerships connected to nitric-oxide based respiratory and infection-treatment technologies, reflecting a strategic focus on differentiated clinical applications and a portfolio approach that spans devices, services and training. Geographic reach is centered on Poland with explicit coverage of Western Poland for ultrasound distribution/maintenance and broader positioning toward Poland and CEE for med-tech introduction and implementation, supported by Warsaw-based corporate presence and multi-line operating websites under the Medinco brand family.

Headquarters
Ul. Rondo Organizacji Narodow Zjednoczonych 1/P.27
Warsaw; Mazowieckie; Postal Code: 00-124

Contact Details: Purchase the Medinco Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Medinco Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Medinco Sp. z o.o. report to view the information.
Incorporation Date:
April 11, 2022
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
65%
Purchase this report to view the information.
20%
Purchase this report to view the information.
15%
Company Performance
Financial values in the chart are available after Medinco Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
7.2%
Total operating revenue
7.26%
Operating Profit/Loss (EBIT)
-41.42%
EBITDA
-36.98%
Net Profit/Loss for the Period
-48.92%
Total Assets
-8.7%
Total Equity
38.43%
Operating Profit Margin (ROS)
-3.73%
Net Profit Margin
-4.42%
Return on Equity (ROE)
-47.48%
Quick Ratio
-0.03%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?